Balance Sheet
Cash Flow Statement
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax RateWages, Salaries and Other
Others
Ratios

VitaNova Life Sciences (YJGJ) Gross Profit (2017 - 2026)

VitaNova Life Sciences (YJGJ) has disclosed Gross Profit for 4 consecutive years, with $260803.0 as the latest value for Q4 2025.

  • For the quarter ending Q4 2025, Gross Profit rose 67.36% year-over-year to $260803.0, compared with a TTM value of $1.7 million through Oct 2025, up 176.29%, and an annual FY2025 reading of $1.6 million, up 317.17% over the prior year.
  • Gross Profit was $260803.0 for Q4 2025 at VitaNova Life Sciences, up from $68781.0 in the prior quarter.
  • Across five years, Gross Profit topped out at $1.2 million in Q2 2025 and bottomed at $26100.0 in Q1 2024.